Hemophilia Drugs Price Analysis and Strategies 2012-2016 & 2016-2021: How the Price Advanced from 2012 and Forecasts to 2021 - Research-and-Markets

DUBLIN, Feb 24, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Hemophilia Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Hemophilia Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Hemophilia market.

The research answers the following questions:

• What are the key drugs marketed for Hemophilia and their clinical attributes? How are they positioned in the Global Hemophilia market?
• What are the unit prices and annual treatment cost for Hemophilia therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
• What are the unmet needs in the global Hemophilia drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Hemophilia?

Research Scope:

• Hemophilia Treatment Options - Identify key drugs marketed and prescribed for Hemophilia in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
• Hemophilia Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Hemophilia
• Market Positioning - Identify how drugs are clinically and commercially positioned in the global Hemophilia market
• Hemophilia Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Hemophilia in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
• Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
• Hemophilia New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan

This research will help executives

• Identify clinical attributes of your competitor drugs
• Find out how the marketed products for Hemophilia are clinically and commercially positioned
• Understand the price of your competitor drugs by countries
• Use Hemophilia drugs price data for market sizing, drug sales forecast, budgeting, competitive intelligence, HEOR, and reimbursement
• Find out the pricing and reimbursement landscape by countries
• Identify the unmet need in global Hemophilia market
• Identify the effective pricing for a new drug

For more information about this report visit http://www.researchandmarkets.com/research/krq72w/hemophilia_drugs

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]